Cargando…
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009
BACKGROUND: A previous study found that 2 of 29 (6.9%) meta-analyses published in high-impact journals in 2009 reported included drug trials’ funding sources, and none reported trial authors’ financial conflicts of interest (FCOIs) or industry employment. It is not known if reporting has improved si...
Autores principales: | Benea, Carla, Turner, Kimberly A., Roseman, Michelle, Bero, Lisa A., Lexchin, Joel, Turner, Erick H., Thombs, Brett D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140556/ https://www.ncbi.nlm.nih.gov/pubmed/32268911 http://dx.doi.org/10.1186/s13643-020-01318-5 |
Ejemplares similares
-
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
por: Turner, Kimberly, et al.
Publicado: (2020) -
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
por: Roseman, Michelle, et al.
Publicado: (2012) -
Financial conflicts of interest among editorialists in high-impact journals
por: Kaestner, V, et al.
Publicado: (2017) -
Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
por: Lexchin, Joel
Publicado: (2019) -
Investigator experiences with financial conflicts of interest in clinical trials
por: Rochon, Paula A, et al.
Publicado: (2011)